GlassScriptPhysician profile
David M Huffman
NPI 1811101256
$162,814.74
in general payments reported to CMS, 2019-2025
79 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $27K · 2021: $13K · 2022: $33K · 2023: $12K · 2024: $12K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $12K · Consulting Fee: $4,103 · Travel and Lodging: $1,682 · Education: $93.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,253.69 |
| Food and Beverage | $11,741.27 |
| Consulting Fee | $4,102.50 |
| Travel and Lodging | $1,681.76 |
| Education | $93.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $89,142.40 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $14,798.91 | 2019-2022 | |
| Insulet Corporation | $11,083.00 | 2019-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $9,115.42 | 2021-2025 | |
| Tandem Diabetes Care, INC. | $7,906.04 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $7,886.97 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Merck Sharp & Dohme LLC | $6,005.94 | 2019-2022 | |
| Abbvie INC. | $1,330.33 | 2019-2025 | |
| Medtronic, INC. | $1,321.59 | 2022-2025 | Minimed 780g, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Mannkind Corporation | $1,251.19 | 2019-2025 | Afrezza |
| Corcept Therapeutics | $1,235.50 | 2019-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $1,063.70 | 2019-2024 | |
| Abbott Laboratories | $1,061.52 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Xeris Pharmaceuticals, INC. | $865.29 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Cequr Corporation | $832.84 | 2022-2025 | Cequr Simplicity |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $801.31 | 2019-2025 | Tepezza, Repatha, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $732.87 | 2019-2024 | Jardiance, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $440.68 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $425.90 | 2022-2025 | |
| Sequel Med Tech, LLC | $419.30 | 2024-2025 | Twiist |
| Amneal Pharmaceuticals LLC | $412.88 | 2019-2025 | Unithroid |
| Antares Pharma, INC. | $260.99 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Amarin Pharma, INC. | $259.40 | 2019-2022 | |
| Ascensia Diabetes Care US INC. | $210.69 | 2020-2021 | |
| Clarus Therapeutics INC. | $200.37 | 2021 | |
| Beta Bionics, INC. | $191.60 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Alexion Pharmaceuticals, INC. | $191.24 | 2019-2025 | Strensiq |
| Shire North American Group INC | $186.98 | 2019 | |
| Lifescan, INC. | $177.67 | 2019-2022 | |
| Eli Lilly and Company | $176.92 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $168.88 | 2023-2025 | Yorvipath |
| Dexcom, INC. | $159.88 | 2020-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $154.71 | 2020-2025 | Nexletol |
| Ibsa Pharma INC. | $149.82 | 2019-2022 | |
| Silk Road Medical, INC. | $136.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.23 | 2019-2022 | |
| Horizon Therapeutics Plc | $126.49 | 2021-2023 | Tepezza |
| Valeritas, INC. | $125.52 | 2019 | |
| Pfizer INC. | $109.34 | 2019-2024 | |
| Rgh Enterprises LLC | $109.07 | 2025 | |
| Alnylam Pharmaceuticals INC. | $80.97 | 2025 | Givlaari |
| Otsuka America Pharmaceutical, INC. | $77.60 | 2024-2025 | Abilify Asimtufii, Rexulti |
| Kyowa Kirin, INC. | $76.32 | 2022-2024 | Crysvita |
| Takeda Pharmaceuticals U.S.A., INC. | $75.20 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $74.56 | 2019-2023 | Livalo |
| Intuity Medical INC | $71.82 | 2022 | |
| Bigfoot Biomedical INC | $64.50 | 2022-2023 | Unity Diabetes Management System |
| Azurity Pharmaceuticals, INC. | $58.08 | 2023 | Adthyza |
| Madrigal Pharmaceuticals | $56.73 | 2025 | Rezdiffra |
| Boston Scientific Corporation | $55.28 | 2023-2025 | General - Erectile Dysfunction |
| Neurocrine Biosciences, INC. | $54.73 | 2024-2025 | |
| Opko Pharmaceuticals, LLC | $48.53 | 2022-2023 | Rayaldee |
| Astellas Pharma US INC | $46.31 | 2024 | Veozah |
| Rhythm Pharmaceuticals, INC. | $44.44 | 2025 | Imcivree |
| Acella Pharmaceuticals, LLC | $43.29 | 2019-2025 | NP Thyroid 60 |
| Alfasigma USA, INC. | $43.05 | 2022 | |
| Companion Medical, INC. | $40.81 | 2020 | |
| Nestle Healthcare Nutrition INC. | $40.38 | 2021 | |
| Collegium Pharmaceutical, INC. | $36.80 | 2025 | Jornay Pm |
| Regeneron Healthcare Solutions, INC. | $35.41 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $34.21 | 2024 | |
| Arbor Pharmaceuticals, INC. | $33.64 | 2020-2021 | |
| Intra-Sana Laboratories | $30.72 | 2024 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Allergan, INC. | $29.99 | 2019 | |
| Tolmar, INC. | $29.91 | 2023-2025 | Jatenzo |
| Medtronic Minimed, INC. | $27.00 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $26.43 | 2020-2022 | |
| Becton, Dickinson and Company | $25.95 | 2021 | |
| Zealand Pharma US, INC. | $24.25 | 2021 | |
| Nevro Corp. | $21.36 | 2023 | Senza |
| Verity Pharmaceuticals INC. | $17.81 | 2024 | Tlando |
| Recordati_rare_diseases_inc. | $15.38 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.13 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$69,478.72 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.